Onward is moving its ARC-EX system towards commercial launch, having submitted a De Novo application to the US Food and Drug Administration in April 2024. The analysis of stimulation parameters ...

Framework to determine stimulation parameters for ONWARD ARC-EX Therapy are published in the journal Neuromodulation: Technology at the Neural Interface Peer-reviewed publication is based on ...

The publication in Neuromodulation: Technology at the Neural Interface provides an evidence-based framework to determine stimulation parameters for ARC-EX Therapy based on analysis of device ...